Greg Stanley
Profile
Greg Stanley served as President-Commercial Operations at Oncimmune Ltd.
and Vice President-Global Sales & Marketing at Vigilant Biosciences, Inc. He obtained an undergraduate degree from the University of Missouri-St. Louis.
Former positions of Greg Stanley
| Companies | Position | End |
|---|---|---|
Oncimmune Ltd.
 Oncimmune Ltd. BiotechnologyHealth Technology Oncimmune Ltd. provides clinical testing services for cancer detection. The firm develops early cancer detection tests for lung, breast, colorectal, prostate, stomach, pancreatic and ovarian cancers. The company was founded by John F. R. Robertson in 2003 and is headquartered in Nottingham, the United Kingdom. | Director/Board Member | - |
Vigilant Biosciences, Inc.
 Vigilant Biosciences, Inc. Medical/Nursing ServicesHealth Services Vigilant Biosciences, Inc. engages in the innovation and development of solutions that aid in the early detection and intervention of cancer. It offers an oral cancer screening kit that include point-of-care product. The firm's products include OncAlert Oral Cancer RAPID Test and OncAlert Oral Cancer LAB Test. The company was founded by Matthew H. J. Kim and Elizabeth Franzmann in 2011 and is headquartered in Fort Lauderdale, FL. | Sales & Marketing | - |
Training of Greg Stanley
| University of Missouri-St. Louis | Undergraduate Degree |
Experiences
Positions held
Linked companies
| Private companies | 2 |
|---|---|
Vigilant Biosciences, Inc.
Vigilant Biosciences, Inc. Medical/Nursing ServicesHealth Services Vigilant Biosciences, Inc. engages in the innovation and development of solutions that aid in the early detection and intervention of cancer. It offers an oral cancer screening kit that include point-of-care product. The firm's products include OncAlert Oral Cancer RAPID Test and OncAlert Oral Cancer LAB Test. The company was founded by Matthew H. J. Kim and Elizabeth Franzmann in 2011 and is headquartered in Fort Lauderdale, FL. | Health Services |
Oncimmune Ltd.
Oncimmune Ltd. BiotechnologyHealth Technology Oncimmune Ltd. provides clinical testing services for cancer detection. The firm develops early cancer detection tests for lung, breast, colorectal, prostate, stomach, pancreatic and ovarian cancers. The company was founded by John F. R. Robertson in 2003 and is headquartered in Nottingham, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Greg Stanley